September 20, 2017 06:59 AM EDT
People
Financing
Startups

From big bio­phar­ma to biotech CEO, John Hous­ton’s R&D jour­ney high­lights a fast-chang­ing world

John Carroll

Editor & Founder

John Hous­ton spent close to 30 years in the ranks of two big bio­phar­ma R&D or­ga­ni­za­tions. There was a decade at GSK fol­lowed by 18 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times